Celularity Inc. is a regenerative and cellular medicines company focused on aging-related and degenerative diseases, leveraging placental biology. Its commercial biomaterials business includes Biovance 3L (tri-layer decellularized dehydrated amniotic membrane) and Rebound product lines sold directly and through distributors. The company also develops placental-derived cellular therapy candidates for cancer, infectious, and degenerative diseases, and operates its own manufacturing and storage facility.
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-05-08 | 2024-12-31 | 0001641172-25-009319 | EDGAR | 124K words |
| 2024-07-30 | 2023-12-31 | 0000950170-24-087886 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011440 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001564590-22-013004 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001213900-21-013228 | EDGAR | — |
| 2020-03-24 | 2019-12-31 | 0001213900-20-007185 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-023467 | EDGAR | 54K words |
| 2025-08-29 | 2025-06-30 | 0001641172-25-026067 | EDGAR | — |
| 2025-08-29 | 2025-03-31 | 0001641172-25-026056 | EDGAR | — |
| 2024-12-06 | 2024-09-30 | 0000950170-24-133799 | EDGAR | — |
| 2024-11-07 | 2024-06-30 | 0000950170-24-122493 | EDGAR | — |
| 2024-10-16 | 2024-03-31 | 0000950170-24-115082 | EDGAR | — |
| 2024-01-03 | 2023-09-30 | 0000950170-24-000474 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042544 | EDGAR | — |
| 2023-05-22 | 2023-03-31 | 0000950170-23-023462 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024523 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028775 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001564590-22-020422 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-10 | 0001493152-26-009471 | EDGAR | 17K words |
| 2026-03-05 | 0001493152-26-009017 | EDGAR | — |
| 2026-01-21 | 0001493152-26-003100 | EDGAR | — |
| 2025-12-23 | 0001493152-25-029033 | EDGAR | — |
| 2025-12-19 | 0001493152-25-028560 | EDGAR | — |
| 2025-12-05 | 0001493152-25-026383 | EDGAR | — |
| 2025-10-28 | 0001493152-25-019839 | EDGAR | — |
| 2025-09-03 | 0001641172-25-026245 | EDGAR | — |
| 2025-08-18 | 0001641172-25-024623 | EDGAR | — |
| 2025-08-12 | 0001641172-25-023231 | EDGAR | — |
163 total filings indexed. 135 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001752828 |
| Ticker | CELU |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.celularity.com |
| Listed | 2021-07-19 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report